193 related articles for article (PubMed ID: 34258272)
1. Early Detection of Radiation-Induced Injury and Prediction of Cognitive Deficit by MRS Metabolites in Radiotherapy of Low-Grade Glioma.
Alirezaei Z; Amouheidari A; Hassanpour M; Davanian F; Iraji S; Shokrani P; Nazem-Zadeh MR
Biomed Res Int; 2021; 2021():6616992. PubMed ID: 34258272
[TBL] [Abstract][Full Text] [Related]
2. Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury.
Zeng QS; Li CF; Zhang K; Liu H; Kang XS; Zhen JH
J Neurooncol; 2007 Aug; 84(1):63-9. PubMed ID: 17619225
[TBL] [Abstract][Full Text] [Related]
3. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
Elias AE; Carlos RC; Smith EA; Frechtling D; George B; Maly P; Sundgren PC
Acad Radiol; 2011 Sep; 18(9):1101-8. PubMed ID: 21820634
[TBL] [Abstract][Full Text] [Related]
4. Metabolic alterations: a biomarker for radiation-induced normal brain injury-an MR spectroscopy study.
Sundgren PC; Nagesh V; Elias A; Tsien C; Junck L; Gomez Hassan DM; Lawrence TS; Chenevert TL; Rogers L; McKeever P; Cao Y
J Magn Reson Imaging; 2009 Feb; 29(2):291-7. PubMed ID: 19161192
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive evaluation of radiation-enhanced glioma cells invasiveness by ultra-high-field (1)H-MRS in vitro.
Xu YJ; Cui Y; Li HX; Shi WQ; Li FY; Wang JZ; Zeng QS
Magn Reson Imaging; 2016 Oct; 34(8):1121-7. PubMed ID: 27215950
[TBL] [Abstract][Full Text] [Related]
6. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
7. Predicting the outcome of grade II glioma treated with temozolomide using proton magnetic resonance spectroscopy.
Guillevin R; Menuel C; Taillibert S; Capelle L; Costalat R; Abud L; Habas C; De Marco G; Hoang-Xuan K; Chiras J; Vallée JN
Br J Cancer; 2011 Jun; 104(12):1854-61. PubMed ID: 21610707
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic performance of magnetic resonance spectroscopy in differentiating high-from low-grade gliomas: A systematic review and meta-analysis.
Wang Q; Zhang H; Zhang J; Wu C; Zhu W; Li F; Chen X; Xu B
Eur Radiol; 2016 Aug; 26(8):2670-84. PubMed ID: 26471274
[TBL] [Abstract][Full Text] [Related]
9. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.
Law M; Yang S; Wang H; Babb JS; Johnson G; Cha S; Knopp EA; Zagzag D
AJNR Am J Neuroradiol; 2003; 24(10):1989-98. PubMed ID: 14625221
[TBL] [Abstract][Full Text] [Related]
10. Spectral changes in postoperative MRS in high-grade gliomas and their effect on patient prognosis.
Czernicki T; Szeszkowski W; Marchel A; Gołebiowski M
Folia Neuropathol; 2009; 47(1):43-9. PubMed ID: 19353433
[TBL] [Abstract][Full Text] [Related]
11. Proxies of cognitive reserve and their effects on neuropsychological performance in patients with mild cognitive impairment.
Liu Y; Cai ZL; Xue S; Zhou X; Wu F
J Clin Neurosci; 2013 Apr; 20(4):548-53. PubMed ID: 23406880
[TBL] [Abstract][Full Text] [Related]
12. Transient metabolic changes observed with proton MR spectroscopy in normal human brain after radiation therapy.
Estève F; Rubin C; Grand S; Kolodié H; Le Bas JF
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):279-86. PubMed ID: 9457810
[TBL] [Abstract][Full Text] [Related]
13. Improving the utility of
Crain ID; Elias PS; Chapple K; Scheck AC; Karis JP; Preul MC
J Neurooncol; 2017 May; 133(1):97-105. PubMed ID: 28555423
[TBL] [Abstract][Full Text] [Related]
14. Cho/Cr ratio at MR spectroscopy as a biomarker for cellular proliferation activity and prognosis in glioma: correlation with the expression of minichromosome maintenance protein 2.
Gao W; Wang X; Li F; Shi W; Li H; Zeng Q
Acta Radiol; 2019 Jan; 60(1):106-112. PubMed ID: 29665708
[TBL] [Abstract][Full Text] [Related]
15. Proton magnetic resonance spectroscopy for radiation encephalopathy induced by radiotherapy for nasopharyngeal carcinoma.
Qiu SJ; Zhang XL; Zhang Y; Jiang M
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):241-6. PubMed ID: 17425962
[TBL] [Abstract][Full Text] [Related]
16. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
[TBL] [Abstract][Full Text] [Related]
17. Proton magnetic resonance spectroscopy of cerebral glioma after irradiation.
Ng SH; Ko SF; Chen WC; Tang LM; Chang CN; Wai YY; Wan YL
Chang Gung Med J; 2001 Nov; 24(11):708-16. PubMed ID: 11820651
[TBL] [Abstract][Full Text] [Related]
18. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.
Bisdas S; Ritz R; Bender B; Braun C; Pfannenberg C; Reimold M; Naegele T; Ernemann U
Invest Radiol; 2013 May; 48(5):295-301. PubMed ID: 23296081
[TBL] [Abstract][Full Text] [Related]
19. Distinction between glioma progression and post-radiation change by combined physiologic MR imaging.
Matsusue E; Fink JR; Rockhill JK; Ogawa T; Maravilla KR
Neuroradiology; 2010 Apr; 52(4):297-306. PubMed ID: 19834699
[TBL] [Abstract][Full Text] [Related]
20. Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy.
Weybright P; Sundgren PC; Maly P; Hassan DG; Nan B; Rohrer S; Junck L
AJR Am J Roentgenol; 2005 Dec; 185(6):1471-6. PubMed ID: 16304000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
